AzTrials
AzTrials

Basketball PerformanceLBPT-VSTNCT07339436

Lower Body Plyometric Training Effects on Upper Body in Basketball Players

A study testing Plyometric Training in people with Basketball Performance, run by Birjand University of Medical Sciences at 1 site in Iran.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

The present study investigates effect of lower body plyometric training on upper body performance, muscle size, hormonal factors, and neuromuscular activity in male basketball players, with a focus on vertical strength transfer (VST). Read more about this study

Who is it for?
Ages 16 to 18 years, men onlyHealthy volunteers can take part
Conditions the study is for
Basketball Performance
What is being tested?
Plyometric Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
50 participants
Where
1 siteIran
Study dates
20 Sep 2024to 20 Mar 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 16 to 18 years
  • Men only
  • Healthy volunteers accepted
  • Child, Adult

Who may be able to join

  • Male basketball players with at least 2 years experience

Who cannot join

  • injury

Trial locations and contacts

1 site in 1 country.

Iran1 site
  • Faculty of Sport Sciences, University of Birjand

    Birjand, South Khorasan Province, 9717434765

Other trials in Iran

About this study

Official title: Effect of Lower Body Plyometric Training on Neuromuscular Adaptations, Hormonal Factors, Functional Performance, and Upper Body Muscle Thickness in Basketball Players

The present study investigates effect of lower body plyometric training on upper body performance, muscle size, hormonal factors, and neuromuscular activity in male basketball players, with a focus on vertical strength transfer (VST). In this semi-experimental study, 50 male basketball players (aged 16-18 years, with at least 2 years of experience) were randomly divided into three groups: combined lower-upper body plyometric training (LUBPT), upper body training (UBPT), and control (CON). The 8-week training program, 3 sessions per week, included hurdle jumps, depth jumps, and dynamic push-ups. Assessments included serum levels of growth hormone and testosterone, muscle thickness (elastography), muscle electrical activity (EMG), and sports performance (overhead medicine ball throw, Sargent jump, long jump) in pre- and post-tests.

Read the detailed description

This semi-experimental study was conducted to investigate the effects of an 8-week lower body plyometric training program on neuromuscular adaptations, hormonal factors, functional performance, and upper body muscle thickness in male basketball players, with a focus on vertical strength transfer (VST).

Fifty male basketball players aged 16-18 years with at least 2 years of competitive experience were recruited and randomly allocated into three groups: Combined Lower-Upper Body Plyometric Training (LUBPT, n=17), Upper Body Plyometric Training only (UBPT, n=18), and Control (CON, n=15). The control group continued regular basketball training without additional plyometric exercises.

The intervention lasted 8 weeks with 3 sessions per week. The plyometric program consisted of lower body exercises (hurdle jumps at 40-60 cm height and depth jumps from a 40 cm box) and upper body exercises (dynamic push-ups). Training volume and intensity progressed gradually over the 8 weeks (sessions 1-8: 2-3 sets of 8-10 repetitions; sessions 9-16: 3-4 sets of 10-12 repetitions; sessions 17-24: 4 sets of 12-15 repetitions), with 60-90 seconds rest between sets and 3 minutes between exercises.

Pre- and post-intervention assessments included:

  • Serum levels of growth hormone and testosterone (blood samples taken in fasting state).
  • Upper body muscle thickness (biceps brachii and pectoralis major) measured using ultrasound elastography.
  • Neuromuscular activity (root mean square, RMS) of anterior brachii, pectoralis major, quadriceps femoris, rectus abdominis, and triceps brachii muscles using surface electromyography (EMG) during standardized movements.
  • Functional performance tests: overhead medicine ball throw, Sargent vertical jump (height and power), and standing long jump.

All measurements were performed 48-72 hours before the start of training and 48-72 hours after the final training session. Statistical analysis was conducted using ANOVA with significance set at p < 0.05.

Being tested
Plyometric Training
Keywords
plyometric training, neuromuscular adaptation, hormonal factors, cross-education

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Plyometric TrainingBehavioural

    8-week plyometric training program, 3 sessions per week. Lower body exercises: hurdle jumps (40-60 cm) and depth jumps (from 40 cm box). Upper body exercises: dynamic push-ups. Progression: increasing sets (2-4) and repetitions (8-15) over 8 weeks. Rest: 60-90 seconds between sets, 3 minutes between exercises. Administered in addition to regular basketball training.

Study groups in NCT07339436
Study groupRoleWhat they receive
Combined Lower-Upper Body Plyometric Training (LUBPT) - n=17ExperimentalCombined Lower-Upper Body Plyometric Training (LUBPT) group received an 8-week plyometric program targeting both lower and upper body, 3 sessions per week (total 24 sessions). Lower body exercises included hurdle jumps (40-60 cm height) and depth jumps (from 40 cm box). Upper body exercises consisted of dynamic push-ups. Progression: Weeks 1-2 (sessions 1-6): 2 sets of 8 reps per exercise; Weeks 3-4 (sessions 7-12): 3 sets of 10 reps; Weeks 5-6 (sessions 13-18): 3 sets of 12 reps; Weeks 7-8 (sessions 19-24): 4 sets of 15 reps. Rest intervals: 60-90 seconds between sets, 3 minutes between exercises. Training was performed in addition to regular basketball practice. Pre- and post-tests assessed neuromuscular adaptations (EMG: pectoralis major, rectus abdominis, triceps brachii), hormonal factors (growth hormone, testosterone), muscle thickness (biceps brachii, pectoralis major via ultrasound elastography), and functional performance (overhead medicine ball throw, Sargent jump height/pow
Receives: Behavioral: Plyometric Training
Upper Body Plyometric Training (UBPT, n=18)ExperimentalUpper Body Plyometric Training (UBPT) group received an 8-week plyometric program targeting only upper body, 3 sessions per week (total 24 sessions). Primary exercise: dynamic push-ups. Progression: Weeks 1-2 (sessions 1-6): 2 sets of 8 reps; Weeks 3-4 (sessions 7-12): 3 sets of 10 reps; Weeks 5-6 (sessions 13-18): 3 sets of 12 reps; Weeks 7-8 (sessions 19-24): 4 sets of 15 reps. Rest intervals: 60-90 seconds between sets. Lower body training was not included; participants continued regular basketball practice. Assessments pre- and post-intervention: serum growth hormone and testosterone levels; muscle thickness of biceps brachii and pectoralis major (ultrasound elastography); EMG activity (RMS) of anterior brachii, pectoralis major, quadriceps femoris, rectus abdominis, triceps brachii; functional tests including overhead medicine ball throw distance, Sargent jump (height and power), and standing long jump.
Receives: Behavioral: Plyometric Training
Control (CON, n=15)No interventionControl (CON) group did not receive any plyometric training intervention. Participants continued their regular basketball training routine (technical/tactical drills, scrimmages) for 8 weeks, 3-5 sessions per week, without additional structured plyometric exercises for lower or upper body. No changes to standard practice schedule. This group served as the non-intervention comparator to assess the specific effects of plyometric training. Pre- and post-assessments (48-72 hours before start and after week 8) included: hormonal measurements (serum growth hormone and testosterone via ELISA); muscle thickness (right/left biceps brachii and pectoralis major using ultrasound elastography); neuromuscular electrical activity (surface EMG RMS during standardized tasks for anterior brachii, pectoralis major, quadriceps femoris, rectus abdominis, triceps brachii); physical performance tests (overhead medicine ball throw distance in meters, Sargent vertical jump height and power in kg m/s, standing

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Overhead medicine ball throw

    Participants stood with feet shoulder-width apart, holding a 2 kg medicine ball at the abdomen with both hands, then brought the ball behind the head with slight knee bend, and performed an explosive and strong throw forward with full force. The distance was measured with a tape measure and considered as overhead medicine ball throw performance [22]. In the above test, electrical activity of pectoralis major, rectus abdominis, quadriceps femoris, Anterior Brachii, and triceps brachii muscles was recorded.

    Measured: Baseline and after 8 weeks

  2. Overhead medicine ball throw

    Participants stood with feet shoulder-width apart, holding a 2 kg medicine ball at the abdomen with both hands, then brought the ball behind the head with slight knee bend, and performed an explosive and strong throw forward with full force. The distance was measured with a tape measure and considered as overhead medicine ball throw performance [22]. In the above test, electrical activity of pectoralis major, rectus abdominis, quadriceps femoris, Anterior Brachii, and triceps brachii muscles was recorded.

    Measured: pre and post intervention

Secondary outcomes (1)
  1. Growth hormone

    For blood sampling, participants were asked to avoid sports activity for at least 48 hours before the test and attend the laboratory between 8-9 AM after 12 hours of fasting. Blood was drawn in a sitting position from the antecubital vein of volunteers in 6 ml amounts by a laboratory expert and collected in test tubes. Then, it was centrifuged for 10 minutes at 5000 rpm, and the separated serum was transferred to microtubes and stored in a -20°C freezer for analysis. Post-test blood sampling was the same as pre-test and 48 hours after the last training session. The highly accurate electrochemiluminescence (ECLIA) method and Siemens IMMULITE 2000 XPi Immunoassay System device with Siemens-specific kits with 0.0001 mIU/L accuracy were used to examine changes in growth hormone and testosterone levels of participants

    Measured: Baseline and after 8 weeks

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jan 2026
  2. Study start20 Sep 2024
  3. Primary completion29 Nov 2024
  4. Study completion20 Mar 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Randomised
Intervention model
Parallel groups
Masking
None (open label)
Enrolment
50 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07339436
Sponsor's protocol ID
Birjand-Plyometric-1403
Other IDs
IR.BIRJAND.REC.1403.016
Acronym
LBPT-VST
Status last verified
Jan 2026
First submitted
5 Jan 2026
Last updated
14 Jan 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Questions about this trial

What is this clinical trial studying?

A study testing Plyometric Training in people with Basketball Performance, run by Birjand University of Medical Sciences at 1 site in Iran.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 1 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 14 Jan 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Overhead medicine ball throw (time frame: Baseline and after 8 weeks). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 14 Jan 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in